Diffuse advanced hepatocellular carcinoma after HCV eradication in an HIV-infected patient: A unique complete response to sorafenib

Turk J Gastroenterol. 2020 Feb;31(2):184-186. doi: 10.5152/tjg.2020.181044.

Authors

Gonçalo Nunes¹, Cristina Fonseca¹, Marta Patita¹, Mario João Aleixo², Miguel Ramalho³, Jorge Fonseca⁴

Affiliations

¹ Department of Gastroenterology, Hospital Garcia de Orta, Almada, Portugal.
² Department of Infectiology, Hospital Garcia de Orta, Almada, Portugal.
³ Department of Radiology, Hospital Garcia de Orta, Almada, Portugal.
⁴ Department of Gastroenterology, Hospital Garcia de Orta, Almada, Portugal;CiiEM, Center for Interdisciplinary Research Egas Moniz, Monte da Caparica, Portugal.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Agents / therapeutic use*
Carcinoma, Hepatocellular / drug therapy*
Carcinoma, Hepatocellular / virology
Coinfection / complications
Coinfection / drug therapy
Coinfection / virology
HIV
HIV Infections / complications
HIV Infections / drug therapy
HIV Infections / virology*
Hepacivirus
Hepatitis C / complications
Hepatitis C / drug therapy
Hepatitis C / virology
Humans
Induction Chemotherapy
Liver Neoplasms / drug therapy*
Liver Neoplasms / virology
Male
Sorafenib / therapeutic use*

Substances

Antineoplastic Agents
Sorafenib